Two decades of network meta‐analysis: Roadmap to their applications and challenges

Abstract

AbstractRecently, Ades and colleagues discussed the controversies and advancements in network meta‐analysis (NMA) over the past two decades, discussing its reliability, assumptions, novel approaches, and provided some useful recommendations for the conduction of NMAs. The present discussion paper builds on the insights by Ades and colleagues, providing a roadmap for NMA applications, advancements in software and tools, and approaches designed to facilitate the assessment and interpretation of NMA findings. It also discusses the impact of NMA across disciplines, particularly for policymakers and guideline developers. Despite 20 years of NMA history, challenges remain in understanding and assessing assumptions, communicating and interpreting findings, and applying common approaches like network meta‐regression and NMA involving non‐randomized studies in readily available software. NMA has proven particularly valuable in clinical decision‐making, which highlights the need for additional training and interdisciplinary collaboration of knowledge users, including patient engagement, to enhance its adoption and address real‐world problems.